Surgical Stents Market Size

Market Size Snapshot

Note – Market size depicts the revenue generated over the financial year

Hence the stents. The surgical stents market is expected to grow at a CAGR of 5.9 per cent from 2019 to 2024. And at a CAGR of 4.3 per cent from 2025 to 2035. The main reason for this growth is the rising prevalence of chronic diseases like heart disease and urological disorders. Also, technological advancements like the development of drug-eluting stents and bioresorbable stents are improving the patient outcomes and promoting the use of these stents in the hospitals. In the surgical stents market, Boston Scientific, Medtronic, and Abbott Laboratories are investing heavily in research and development to improve their product offerings. Strategic initiatives like acquisitions, mergers, and collaborations are also increasing. The focus on minimally invasive techniques and improved biocompatibility is expected to further drive the surgical stents market.

Regional Market Size

Regional Deep Dive

Among the most important features of the stents market is the increasing demand for minimally invasive procedures. The North American market is characterized by a high prevalence of cardiovascular diseases and a well-developed healthcare system, while Europe is characterized by high compliance with regulations and innovation. The Asia-Pacific region is experiencing high growth due to increasing health expenditure and an expanding patient population, while the Middle East and Africa are characterized by difficulties in accessing and paying for medical care. Latin America is gradually adopting the most advanced stents, influenced by both economic and health reforms aimed at improving the quality of life of patients.

Europe

• The European Union has implemented stricter regulations regarding medical devices, leading to increased scrutiny of stent safety and efficacy, which is pushing manufacturers to innovate and comply with higher standards.
• Companies such as Abbott and B. Braun are collaborating with healthcare providers to conduct clinical trials for new stent technologies, aiming to address specific regional health challenges like coronary artery disease.

Asia Pacific

• Countries like India and China are experiencing a surge in demand for surgical stents due to rising incidences of lifestyle-related diseases, prompting local manufacturers to enter the market with cost-effective solutions.
• Government initiatives in countries such as Japan are promoting the adoption of advanced medical technologies, including stents, to improve healthcare outcomes and reduce the burden of chronic diseases.

Latin America

• Regulatory changes in Brazil and Mexico are facilitating the entry of new stent technologies, which is expected to enhance competition and improve patient access to advanced treatments.
• Healthcare reforms in several Latin American countries are focusing on expanding insurance coverage for surgical procedures, which is likely to increase the demand for surgical stents.

North America

• The FDA has recently approved several new biodegradable stents, which are expected to enhance patient recovery times and reduce long-term complications, thus driving market growth.
• Key players like Boston Scientific and Medtronic are investing heavily in R&D to develop next-generation stents, focusing on drug-eluting technologies that improve efficacy and reduce restenosis rates.

Middle East And Africa

• The healthcare sector in the Middle East is undergoing transformation, with investments in advanced medical technologies, including stents, driven by government programs aimed at enhancing healthcare infrastructure.
• Local companies are increasingly partnering with international firms to bring innovative stenting solutions to the region, addressing the unique healthcare challenges faced by patients in these markets.

Did You Know?

“Approximately 1.5 million coronary stent procedures are performed annually in the United States alone, highlighting the critical role of stents in modern cardiovascular care.” — American College of Cardiology

Segmental Market Size

The stents market is currently experiencing a stable growth, mainly driven by the growing number of patients suffering from chronic diseases such as heart problems and the rising demand for minimally invasive procedures. Moreover, the increasing availability of drug-eluting stents, which improve patient outcomes, as well as the favourable regulatory framework that facilitates the approval of new products, will help to propel this market. Medtronic and Boston Scientific are leading the way in this market. They are reaping the benefits of a favourable regulatory framework in the developed countries of North America and Europe where the healthcare system is well equipped to support such advanced surgical procedures. In these regions, stents are primarily used to treat heart disease and urological conditions. They are mostly employed in hospitals and specialised clinics. This trend is also being driven by macroeconomic factors such as the aging population and the increasing focus on cost-effective treatment. The development of new products, such as bioresorbable stents and new diagnostic tools, will ensure that stents remain a vital part of modern medical practice.

Future Outlook

The stents market is expected to grow at a CAGR of 4.83% from 2024 to 2035. The stents market is mainly driven by the increasing prevalence of chronic diseases, such as urological and cardiovascular diseases, which require the use of stents for effective treatment. The growing trend towards minimally invasive surgery will also drive the demand for advanced stents, which will lead to higher penetration rates in surgical practices. Stent usage in surgical procedures is expected to reach more than 30% of eligible patients by 2035, as improved patient outcomes and enhanced surgical efficiencies are realized. The stents market will also be driven by technological developments, such as the development of bioresorbable stents and drug-eluting stents. These innovations not only reduce the risk of complications, but also improve the patient's recovery time, thereby increasing the preference of physicians. Supportive reimbursement policies for medical devices will also lead to an increase in market penetration. Emerging trends, such as the integration of digital health and telemedicine in post-operative care, will also play a critical role in shaping the future of the stents market. , the post-operative follow-up process is more efficient and effective.